AbbVie (ABBV) Raw Materials (2012 - 2016)

AbbVie (ABBV) has reported Raw Materials for 5 consecutive years, with $132.0 million the latest figure, recorded in Q2 2016.

• On a quarterly basis, Raw Materials rose 4.76% year-over-year to $132.0 million in Q2 2016; TTM through Jun 2016 was $132.0 million, a 4.76% increase from a year earlier, with the FY2015 full-year figure at $169.0 million, up 9.74% from the prior year.
• Raw Materials was $132.0 million for Q2 2016 at AbbVie, down from $155.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $261.0 million in Q4 2013 and troughed at $126.0 million in Q2 2015.
• A 5-year average of $188.2 million and a median of $163.0 million in 2015 frame the typical range for Raw Materials.
• The widest YoY moves for Raw Materials: up 9.74% in 2015, down 45.02% in 2015.
• Over 5 years, Raw Materials stood at $258.0 million in 2012, then advanced by 1.16% to $261.0 million in 2013, then tumbled by 41.0% to $154.0 million in 2014, then gained by 9.74% to $169.0 million in 2015, then decreased by 21.89% to $132.0 million in 2016.
• The last three Raw Materials figures came in at $132.0 million (Q2 2016), $155.0 million (Q1 2016), and $169.0 million (Q4 2015), per Business Quant data.